Silent Footprints of Ebolavirus in the Forest: Serological Clues from Wild Non-Human Primates in the Democratic Republic of Congo

This study demonstrates the feasibility of non-invasive fecal serology to detect prior Ebola virus exposure in free-ranging non-human primates in the Democratic Republic of Congo, providing the first evidence of cryptic viral circulation in *Cercopithecus ascanius* and *C. wolfi* despite the absence of active outbreaks.

The Gist

Imagine the African rainforest as a giant, bustling city where humans and wild animals live in close neighborhoods. In this city, there's a very dangerous, invisible "ghost" called the Ebola virus. Usually, we only know the ghost is there when it haunts a house (causes an outbreak) and makes people very sick. But what is the ghost doing when no one is sick? Is it hiding in the walls, or has it left the building entirely?

This paper is like a team of detectives trying to find out if the ghost is still lurking in the forest, even when the streets are quiet.

The Mystery: The Silent Forest

The detectives (scientists) went to the Mabali Forest Reserve in the Democratic Republic of Congo. They knew that Ebola had caused trouble there in the past, but right now, there were no outbreaks. The big question was: Is the virus still circulating secretly among the wild monkeys?

Usually, to check for a virus, you have to catch an animal, take its blood, and test it. But catching wild monkeys is like trying to catch a hummingbird with your bare hands—it's hard, stressful for the bird, and you might miss the ones that are healthy.

The New Tool: The "Poop Detective"

Instead of catching the monkeys, the scientists used a clever, non-invasive trick: Fecal Serology.

Think of it like this: When a person gets sick or recovers from a virus, their body leaves "footprints" (antibodies) in their waste. The scientists collected 630 piles of monkey poop from the forest floor. They didn't need to see the monkeys; they just needed the evidence the monkeys left behind.

They split the job into two parts:

1. The "Active Search" (PCR): They looked for the virus itself (the ghost's actual body) in the poop. Result: Nothing found. The virus wasn't actively shedding in the samples.
2. The "Memory Search" (Serology): They looked for the "footprints" (antibodies) that prove the monkey's immune system had fought the ghost in the past. This is like finding a scar on a wall that proves a burglar was there years ago, even if they aren't there now.

The Big Discovery

The "Active Search" came up empty, which is good news for the immediate safety of the area. But the "Memory Search" found something fascinating!

Out of nearly 600 monkeys identified by their DNA (using the poop), 4 monkeys had these "footprints."

• Two were Red-tailed Monkeys (Cercopithecus ascanius).
• Two were Wolf's Monkeys (Cercopithecus wolfi).

These monkeys had clearly met the Ebola virus before, fought it off, and survived. They were the "survivors" of a silent battle.

Why This Matters

The scientists realized that just because you can't find the virus right now (no active infection), it doesn't mean the virus isn't there at all. It might be hiding, circulating quietly at a very low level, like a whisper in a crowded room.

• The "Sentinels": These monkeys act like canaries in a coal mine. Because they live on the edge of the forest where humans and nature mix, they are the first to encounter the virus. If they have antibodies, it means the virus is circulating nearby, even if no one is sick yet.
• The "Ghost" Strategy: The virus might be playing hide-and-seek. It infects a few animals, they survive and carry the memory of it, and then the virus waits for the right moment (maybe when the forest is disturbed or humans get too close) to strike again.

The Takeaway

This study is a breakthrough because it proves we can use poop to track dangerous viruses without hurting the animals. It's like having a superpower to see the "invisible history" of a forest.

The main lesson? Silence doesn't mean safety. Just because there are no outbreaks today doesn't mean the virus has left the forest. It's just sleeping. By watching these "silent footprints" in the monkeys, we can wake up and prepare before the next big outbreak happens.

In short: The scientists found proof that Ebola has been visiting these monkeys in the past, even though the forest looks quiet right now. This gives us a new, gentle way to keep an eye on the virus and protect both the forest and the people living near it.

Technical Summary

1. Problem Statement

Filoviruses, particularly Ebola virus (EBOV), cause severe hemorrhagic fevers with high mortality rates in humans. While bats are suspected reservoirs, the precise ecological dynamics of viral circulation in wildlife during inter-epidemic periods remain poorly understood.

• Limitations of Current Surveillance: Molecular detection (PCR) of viral RNA in wildlife is often limited by low viral loads, intermittent shedding, and the logistical/ethical difficulties of invasive sampling (capturing and drawing blood from wild animals).
• The Gap: There is a lack of data on "silent" or cryptic viral circulation in free-ranging non-human primates (NHPs) in endemic regions like the Democratic Republic of Congo (DRC), specifically during periods without active outbreaks.
• Objective: To investigate EBOV exposure in free-ranging NHPs in the Mabali Forest Reserve (Equateur Province, DRC) using a non-invasive fecal serology approach to detect past exposure rather than just active infection.

2. Methodology

The study employed a multi-step, non-invasive workflow on 630 fecal samples collected from the ground in the Mabali Forest Reserve between December 1–20, 2023.

• Sample Processing:

  • Samples were divided into three aliquots.
  • Aliquot 1 (Inactivation & PCR): Samples were inactivated (BSL-2 protocol) and screened for active EBOV infection via qPCR targeting the nucleoprotein (NP) gene.
  • Aliquot 2 (Species ID): DNA was extracted to verify sample quality (bacterial 16S rRNA qPCR) and identify primate species via mitochondrial 16S DNA gene sequencing.
  • Aliquot 3 (Serology): Feces were resuspended in PBS with protease inhibitors, centrifuged, filtered, and lyophilized to extract proteins for antibody detection.

• Serological Analysis (The Core Innovation):

  • Platform: Automated capillary Western blot system (Jess™, ProteinSimple).
  • Antigens: Recombinant Zaire EBOV antigens: Nucleoprotein (NP), Glycoprotein (GP), and Viral Protein 40 (VP40).
  • Criteria for Positivity: A strict sequential algorithm was used to minimize false positives:
    1. Initial screening for NP reactivity (~22 kDa).
    2. Confirmatory testing for GP reactivity (~69 kDa) on NP-positive samples.
    3. Definition: Only samples showing double reactivity (NP + GP) were classified as seropositive. VP40 detection served as supportive evidence.
  • Controls: A validated positive control (survivor serum) defined the threshold.

3. Key Results

• Molecular Screening (Active Infection):

  • All 630 samples tested negative for EBOV RNA via qPCR. This confirms the absence of active outbreaks in the sampled population at the time of collection.

• Species Identification:

  • Molecular identification was successful in 569 samples (90.3%).
  • Dominant Species: Cercopithecus ascanius (62.2%), followed by Lophocebus aterrimus (26.0%) and Cercopithecus wolfi (10.7%).

• Serological Findings (Past Exposure):

  • Overall Seroprevalence: 0.70% (4 out of 569 identified samples).
  • Positive Species:
    • Cercopithecus ascanius: 2 positive (0.56% of 354).
    • Cercopithecus wolfi: 2 positive (3.27% of 61).
  • Negative Species: No seroreactivity was found in L. aterrimus, Allenopithecus nigroviridis, C. nictitans, or Perodicticus potto.
  • Profile: All four positive samples showed discrete immunoreactive bands for NP and GP, consistent with EBOV-specific antibodies.

4. Key Contributions

1. First Serological Evidence in Specific Taxa: This study provides the first evidence of EBOV exposure in Cercopithecus ascanius and C. wolfi. Previous studies focused largely on great apes or bats.
2. Validation of Non-Invasive Fecal Serology: The study successfully demonstrates that automated capillary Western blotting (Jess) is a feasible, high-specificity tool for detecting anti-Ebola antibodies in fecal extracts, overcoming the degradation issues often associated with non-invasive samples.
3. Evidence of "Silent" Circulation: The detection of antibodies in the absence of viral RNA supports the hypothesis of cryptic or low-level viral circulation in forest ecosystems during inter-epidemic periods, which PCR alone would miss.
4. Refined Detection Algorithm: The study establishes a rigorous, conservative interpretation protocol (requiring dual NP/GP reactivity) to ensure high specificity in complex environmental samples, reducing cross-reactivity risks.

5. Significance and Implications

• Ecological Sentinels: The findings suggest that generalist, frugivorous primates like C. ascanius and C. wolfi, which inhabit forest edges and ecotones, may act as ecological sentinels or bridge hosts. Their presence at the human-wildlife interface makes them critical for monitoring zoonotic spillover risks.
• One Health Surveillance: The research validates a One Health framework where non-invasive fecal serology can be integrated into routine surveillance. This allows for the monitoring of viral dynamics without disturbing wildlife or requiring capture, making large-scale, longitudinal studies possible.
• Risk Assessment: The low seroprevalence (0.70%) should not be interpreted as a lack of risk. Instead, it represents a baseline "silent" signal of viral presence. In the context of increasing forest fragmentation and anthropogenic pressure in Central Africa, detecting these low-level signals is crucial for anticipating future outbreaks.
• Methodological Shift: The study argues that relying solely on molecular (PCR) detection is insufficient for understanding the full epidemiology of filoviruses. Integrating serology is essential to capture the history of exposure and the true extent of viral circulation in wildlife reservoirs.